Albany, NY -- (SBWIRE) -- 04/03/2017 -- Human Vaccines Market: Scope and Methodology
This report provides in-depth region wise and country wise analysis of the human vaccines market. Stakeholders of this report include manufacturers of human vaccines products, raw material suppliers, vaccine processing companies, and new players planning to enter the market.
The report provides qualitative and quantitative analysis of the global human vaccines market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes market share held by companies in 2015, market size, and forecast for the global human vaccines market in major countries globally such as the U.S., Canada, Germany, France, United Kingdom, Italy, Spain, Japan, China, Brazil, Mexico, South Africa and GCC countries. Market revenue is provided in terms of US$ Mn from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 for all the segments, considering 2015 as the base year. The executive summary of the report provides a snapshot of the human vaccines with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.
The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global human vaccines market. These factors would aid the stakeholders in establishing a strong foothold in the global human vaccines market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the human vaccines. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market. Market share analysis is also provided in the competitive landscape section of the report for the year 2015 in terms of value (%).
Human Vaccines Market: Snapshot
Vaccination has been promoted as a vital public health intervention across the globe for decades. According to the World Health Organization (WHO), vaccination has reduced the global burden of infectious disease to a great extent. An extremely low risk of serious and fatal side effects associated with vaccines and growing awareness regarding vaccination by various government and non-profit organizations are the key factors driving the human vaccines market.
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. Extensive promotion and marketing strategies and favorable government support are likely to boost market growth.
Browse full report on Human Vaccines Market -
http://www.transparencymarketresearch.com/human-vaccines-market.html
Human Vaccines Market: Segmentation
The human vaccines market has been segmented as vaccine type, products, age group, distribution channel and geography. Based on vaccine type, the market has been segmented into conjugate, recombinant, inactivated, combination, attenuated, and others. Likewise, on basis of product the market has been categorized into pneumococcal, influenza, hepatitis, HPV, meningococcal, rotavirus, measles and mumps, typhoid, combination and others. By age group the market is categorized into pediatrics, adolescent, adult and geriatrics. Hospital pharmacies, drugstores and others are included into the market by distribution channel
Geographically, the human vaccines market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Italy, Spain, Japan, China, Brazil, Mexico, and South Africa have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the human vaccines market in various regions has been provided in this section. This report also includes various ups and downs about particular country or geography that has impacted the overall market globally.
Human Vaccines Market: Competitive Landscape
The report provides a detailed outline/blueprint of the human vaccines market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Major players operating in the global human vaccines market include AstraZeneca, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer, Inc., Sanofi and Johnson & Johnson among others.
Request for sample of this report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16127